Table 1.

Patient Adherence to Pap Follow-up Recommendations

200320042005
Colposcopy completed within 1 year:
    All ages: n/N (%)79/112 (71%)44/70 (63%)62/111 (56%)
    Age ≥21: n/N (%)69/94 (73%)38/63 (60%)57/99 (57%)
    Age <21: n/N (%)10/18 (56%)6/7 (86%)5/12 (42%)
Colposcopy completed within 90 days:
    All ages: n/N (%)51/112 (46%)32/70 (46%)39/111 (35%)
    Age ≥21: n/N (%)44/94 (47%)26/63 (41%)36/99 (36%)
    Age <21: n/N (%)7/18 (39%)6/7 (86%)3/12 (25%)
Gynecological treatment of CIN II-III:
    Ever completed: n/N (%)6/12 (50%)2/5 (40%)0/0*
    Completed within 90 Days: n/N (%)4/12 (33%)1/5 (20%)0/0*
Cases seemingly lost to follow-up:
    Cases within the 1 calendar year: n/N (%)491/3551 (14%)478/5072 (9%)570/6161 (9%)
    Since October 1999, of nonpurged cases (in 50-, 62-, and 74-month periods respectively): n/N (%)569/3551 (16%)948/5072 (19%)1376/6161 (22%)
Completion of a follow-up Pap or a colposcopy within subsequent 3 years:
    All patients included, no exclusions: n/N (%)Unavailable173/203 (85%)570/625 (91%)
    Excluding patients verified lost from DH's Community Health-FQHC system: n/N (%)Unavailable173/175 (99%)570/576 (99%)
  • * We first had HPV high-risk reflex testing available to us in March 2005.

  • Unavailable under our older database versions.

  • Patients considered ″lost″ are those not seen anywhere in Denver Health's Hospital and Clinic system after the date targeted for their follow-up.